A Phase 2 Trial of Pridopidine in ALS, Studied as a Regimen with the Healey Platform Trial

This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features:

Jeremy M. Shefner, MD, PhD
Professor of Neurology
Barrow Neurological Institute

Learn More